🇺🇸 FDA
Patent

US 9518056

Inhibitors of influenza viruses replication

granted A61KA61K31/506A61K31/5377

Quick answer

US patent 9518056 (Inhibitors of influenza viruses replication) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/506, A61K31/5377, A61K31/55, A61K31/553